| 9/15/2021 |
VitalConnect Introduces New VistaCenter With Powerful Workflow Capabilities to Maximize Clinical Efficiency |
hmpgloballearningnetwork.com |
Market-leading workflow with historical and real-time patient data monitoring allows exceptional ease of patient managementSAN JOSE, Calif. – VitalConnect ® , Inc. , a leader in remote and in-hospital wearable biosensor technology , announced it has launched its new version of VistaCenter for cardiac and remote patient monitoring. This new version brings market-leading patient management and monitoring tools such as simplified patient intake, live patient census views, custom ... |
| 9/14/2021 |
VitalConnect Introduces New VistaCenter With Powerful Workflow Capabilities to Maximize Clinical Efficiency | Financial Buzz |
financialbuzz.com |
VitalConnect ® , Inc. , a leader in remote and in-hospital wearable biosensor technology , today announced it has launched its new version of VistaCenter for cardiac and remote patient monitoring. This new version brings market-leading patient management and monitoring tools such as simplified patient intake, live patient census views, custom notification profiles and report delivery—all designed to streamline workflow and make patient management easier and less time-intensive for ... |
| 9/13/2021 |
iRhythm gets back on beat, tapping former Dexcom exec as CEO |
FierceBiotech |
... and president of the San Francisco-based company, effective Oct. 4. At that time, he’ll also join iRhythm’s board of directors.Blackford comes to iRhythm with a wealth of experience in both biosensor technology and the medical device market as a whole. Most recently, he spent four years at Dexcom, maker of under-the-skin continuous glucose monitoring technology. At Dexcom, he served first as chief financial officer ... |
| 9/13/2021 |
Y2X Life Sciences Completes Option Agreement for SARS-CoV-2 Detection Technology from Washington University in St. Louis |
Yahoo News |
... and aerosol detectors that monitor indoor air quality for the presence of SARS-CoV-2 in large gathering places such as airports, conference halls, government facilities, military installations and vessels and schools.The licensed biosensor technology was developed in a multidisciplinary collaborative effort by researchers from the School of Medicine and McKelvey School of Engineering at Washington University in St. Louis. The team was led by John Cirrito, PhD, associate ... |
| 9/13/2021 |
Y2X Life Sciences Completes Option Agreement for SARS-CoV-2 Detection Technology from Washington University in St. Louis |
digitalmedianet.com |
... and aerosol detectors that monitor indoor air quality for the presence of SARS-CoV-2 in large gathering places such as airports, conference halls, government facilities, military installations and vessels and schools.The licensed biosensor technology was developed in a multidisciplinary collaborative effort by researchers from the School of Medicine and McKelvey School of Engineering at Washington University in St. Louis. The team was led by John Cirrito, PhD, associate ... |
| 9/13/2021 |
Y2X Life Sciences Completes Option Agreement for SARS-CoV-2 Detection Technology from Washington University in St. Louis | Financial Buzz |
financialbuzz.com |
... and aerosol detectors that monitor indoor air quality for the presence of SARS-CoV-2 in large gathering places such as airports, conference halls, government facilities, military installations and vessels and schools.The licensed biosensor technology was developed in a multidisciplinary collaborative effort by researchers from the School of Medicine and McKelvey School of Engineering at Washington University in St. Louis. The team was led by John Cirrito, PhD, associate ... |
| 9/10/2021 |
Chutes & Ladders—Former FDA Commissioner Hahn takes interim CMO role at YourBio Health |
FierceBiotech |
... first chief medical officer Glympse BioTram Tran , M.D., will be the first chief medical officer at Glympse Bio.After leading the global liver diseases unit for Gilead Sciences, Tran will oversee the injectable biosensor technology at Glympse. Tran will help move the technology through clinical development and across the FDA approval finish line. She is a practicing liver and viral specialist. Glympse's lead indication for the biosensors is the ... |
| 9/8/2021 |
Glympse Bio names first medical chief, offering a peek at the clinical future of its disease-spotting biosensors |
FierceBiotech |
With its injectable biosensor technology well into the clinical development stage, Glympse Bio has its sights set on revolutionizing the way we diagnose diseases and track their progression throughout the body.Helping Glympse along its path through trials, FDA approval and beyond will be Tram Tran, M.D., who joins the Cambridge, Mass.-based company as its first-ever chief medical officer.At Glympse, Tran will combine her experience as both ... |
| 9/8/2021 |
Glympse Appoints Tram Tran, M.D., as Chief Medical Officer |
tncontentexchange.com |
... and biopharmaceutical expertise to our leadership team," said Caroline Loew, Ph.D., Chief Executive Officer of Glympse. "Her experience in the field of hepatology is particularly relevant as the company progresses the development of our biosensor technology for its lead indication of NASH." Dr. Tran added, "Glympse's biosensor technology has the potential to fundamentally reshape the diagnosis and monitoring of liver and other diseases. This is a real need that we ... |
| 9/8/2021 |
Glympse Appoints Tram Tran, M.D., as Chief Medical Officer |
PR Newswire |
... and biopharmaceutical expertise to our leadership team," said Caroline Loew , Ph.D., Chief Executive Officer of Glympse. "Her experience in the field of hepatology is particularly relevant as the company progresses the development of our biosensor technology for its lead indication of NASH."Dr. Tran added, "Glympse's biosensor technology has the potential to fundamentally reshape the diagnosis and monitoring of liver and other diseases. This is a real need that we ... |
| 9/6/2021 |
Global Market for Advanced Materials in Biosensors: Graphene to Play a Vital Role in the Development of Biosensor Technology |
PR Newswire |
... Process and Methodology 2.4 Summary of Key Findings3. Technology Overview 3.1 Overview and Competencies of Advanced Materials for Sensors 3.2 Biosensors Addressing Common Needs in the Market 3.3 Role of Advanced Materials in Biosensor Technology Development 3.4 Graphene as an Essential Material in Biosensor Development 3.5 Conducting Polymers Gaining Attention in Biosensor Applications 3.6 CNT Materials Important for Developing Unique Biosensor Devices4. Application Impact Analysis, Driving and Challenging ... |
| 9/6/2021 |
Global Market for Advanced Materials in Biosensors: Graphene to Play a Vital Role in the Development of Biosensor Technology |
Yahoo News |
... Process and Methodology2.4 Summary of Key Findings3. Technology Overview3.1 Overview and Competencies of Advanced Materials for Sensors3.2 Biosensors Addressing Common Needs in the Market3.3 Role of Advanced Materials in Biosensor Technology Development3.4 Graphene as an Essential Material in Biosensor Development3.5 Conducting Polymers Gaining Attention in Biosensor Applications3.6 CNT Materials Important for Developing Unique Biosensor Devices4. Application Impact Analysis, Driving and Challenging ... |
| 9/3/2021 |
Emerging Opportunities of Advanced Materials in Biosensors: Advancements in Nanotechnology-based Materials Encouraging Biosensor Development in Remote Health Monitoring Applications – ResearchAndMarkets.com |
digitalmedianet.com |
... Process and Methodology2.4 Summary of Key Findings3. Technology Overview3.1 Overview and Competencies of Advanced Materials for Sensors3.2 Biosensors Addressing Common Needs in the Market3.3 Role of Advanced Materials in Biosensor Technology Development3.4 Graphene as an Essential Material in Biosensor Development3.5 Conducting Polymers Gaining Attention in Biosensor Applications3.6 CNT Materials Important for Developing Unique Biosensor Devices4. Application Impact Analysis, Driving and Challenging ... |
| 9/2/2021 |
On-Body Biosensors: a Human Factors Development Approach |
pr.com |
... the event website: www.biosensors-medical-wear.com/pr5PRCOM Key sessions not to be missed at Medical Wearables for Biosensors USA conference: On-body biosensors: A human factors development approach What’s new in On-Body Biosensor Technology Meeting the needs by being Patient Centric Updated Human Factors regulation Biosensor Life Cycle Management embraces cutting edge Innovation Jim Leamon, Director of Biologics Device Development, Jazz Pharmaceuticals Technology and design considerations in developing ... |
| 9/1/2021 |
Biosensors Market to See Huge Growth by 2027 |
knnit.com |
... and company profiles. The report is a prototype of the thorough investigation of the Biosensors market and serves as a valuable source of data and information pertaining to the market. Shortly, technical developments in biosensor technology will accelerate the pace of biosensor adoption. The modern techniques of biosensors offer creative, user friendly, and versatile goods. Combining this application with the internet of things, tablets, cloud storage, and a few other ... |
| 8/31/2021 |
On-body biosensors: A human factors development approach |
einnews.com |
... event website: [www.biosensors-medical-wear.com/pr5EINNEWS] Key sessions not to be missed at Medical Wearables for Biosensors USA conference: On-body biosensors: A human factors development approach •What’s new in On-Body Biosensor Technology •Meeting the needs by being Patient Centric •Updated Human Factors regulation •Biosensor Life Cycle Management embraces cutting edge Innovation Jim Leamon, Director of Biologics Device Development, Jazz [Pharmaceuticals] Technology and design ... |
| 8/31/2021 |
Coronavirus company news summary – Empowered Diagnostics submits updated EUA to FDA for rapid test – Purdue University researcher creates paper-based Covid test |
medicaldevice-network.com |
... 33 countries, INDICAID also holds EUA from the FDA and the European CE Mark. A researcher at Purdue University has developed a quick and cost-effective paper-based Covid-19 test based on a biosensor technology used to identify Bovine Respiratory Disease (BRD) in cattle using nasal swabs. The new test, by agricultural and biological engineering assistant professor Mohit Verma, provides results in 60 minutes with an analytical specificity of ... |
| 8/31/2021 |
Purdue researcher develops fast, accurate, and affordable COVID-19 paper-based test; clinical trials await |
wbiw.com |
... 2021WEST LAFAYETTE – When the COVID-19 pandemic began and the technologies necessary to combat it came into focus, testing was immediately identified as being top on the list. Mohit Verma displays the biosensor technology used to develop his rapid response COVID-19 tests. Photo provided by Mohit VermaMohit Verma, assistant professor of agricultural and biological engineering, had been working for years on developing a diagnostic tool to ... |
| 8/27/2021 |
Disposable Medical Device Sensors Market Segmentation: Based on Product, Application and Region by 2015 – 2021 |
tradersherald.com |
... are the fastest growing sub-segment in the global disposable medical device sensors market. Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/4492?source=atm Based on sensor technologies, the report covers biosensor technology , image sensor technology, pressure sensor technology, accelerometer sensor technology, and temperature sensor technology. On the basis of medical applications, the report covers patient monitoring, and diagnostic and therapeutic applications of medical sensors. In terms ... |
| 7/26/2021 |
$2.34 billion in Biosensors in Life Sciences Market from Life Sciences Tools & Services Industry | Discover Company Insights in Technavio |
PR Newswire |
... the overall market environment. The market is driven by factors such as the advantages of biosensors in drug analysis, the increasing demand for rapid detection methods for identifying foodborne pathogens, and the advances in biosensor technology .The biosensors in life sciences market analysis include application and geography landscape segments. This study identifies the advances in biosensor technology as one of the prime reasons driving the biosensors in life sciences market ... |